Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Real-Time Apneic Screening Device

By Biotechdaily staff writers
Posted on 12 Jan 2007
A small, easy-to-use, and unobtrusive device allows screening for apneic events in persons who may be suspected of having obstructive sleep apnea (OSA). More...


The battery-powered RUSleeping real time screening (RTS) device consists of a base unit and a nasal cannula. Respiratory airflow pressure is sensed via the cannula and the device starts to record apneic events. When breathing decreases by 50% or more for 10 seconds or longer, it is considered an apneic event and is recorded on the liquid crystal display (LCD) readout. The device is convenient to operate and can be re-used. No accessory equipment, software, or electrical outlet is needed.

Based upon a patient's at-home overnight score, physicians can interpret if the patient is a likely candidate for an immediate polysomnogram (PSG). Sleep lab physicians can provide the RUSleeping RTS to patients to pre-screen at home for OSA before the patient is seen for an in-lab PSG. By being presented with objective data regarding their apneic events, patients may more readily accept the need for a complete PSG and consequent treatment, if needed. The RUSleeping RTS is manufactured by Respironics (Murrysville, PA, USA).

"The RUSleeping RTS device is much less cumbersome and expensive than many other screening devices. It is a quick and simple tool for busy clinicians who have patients presenting with subjective symptoms of OSA,” said Respironics product manager Rick Herrle. "This may help bring patients one step closer to diagnosis and treatment, which is what good patient outcomes are all about.”



Related Links:
Respironics

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.